Pierre Fabre Laboratories’ Post

Alma Zhylkaidarova shares the experience of colorectal cancer screening in Kazakhstan, highlighting the process, challenges, and the importance of early detection.🎗️ Join us on the Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer. Follow the link below: https://lnkd.in/dNgP7N6U #Cancer #ColorectalCancer #GlobalCancerMovement #Medicine #CancerScreening #EarlyDetection #MedicalEvent #Conference #Health #Oncology #OncoDaily

Look forward to fruitful discussions and exchanges on lung cancer screening in the Asia Pacific region - Herbert Loong, MBBS FRCP FASCO Lung Cancer Policy Network Asia Pacific Coalition against Lung Cancer https://lnkd.in/ebf4WCBc #ACLC24 #LungCancer #Cancer #CancerScreening #Oncology #Healthcare #OncoDaily 

🌟 We’re honored to introduce Michael Sapienza (USA) as a speaker at the Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer, taking place online from December 6-8, 2024! Mr. Sapienza will be presenting on “Project Cure CRC - Ending Colorectal Cancer in our lifetime.” 📅 Save the date and join us for three days of insightful discussions alongside world-renowned experts, patient advocates, and global healthcare leaders. Colorectal Cancer Alliance 👉 To learn more or register, click here: https://lnkd.in/dNgP7N6U #GlobalCancerMovement #ColorectalCancer #PatientAdvocacy #OncoDaily #HealthcareLeadership #Oncology #Cancer

Survival Chances of Lung Cancer with Early Diagnosis In this video, Dr Jovita Martin Daniel, a renowned oncologist at MGM Cancer Institute, shares insights into the survival rates of lung cancer when detected early. Discover how early diagnosis, combined with advanced treatments, can greatly improve a patient’s chances of survival and quality of life. Timely detection can save lives. Learn more about the importance of regular screenings, early symptoms, and the latest breakthroughs in lung cancer care. 🔗 Learn more about Dr. Jovita Martin Daniel: [https://lnkd.in/gwdNNJS8) #LungCancer #EarlyDiagnosis #CancerSurvival #DrJovitaMartinDaniel #CancerTreatment #OncologyCare #MGMCares #WeCureFearFirst #CancerAwareness #LungCancerSurvival #CancerScreening #PatientCare #Oncology #MGMCancerInstitute #FightingCancer

Discussing RET, NTRK and NRG1 in patients with lung cancer in ecancer interview - Luis E Raez Memorial Healthcare System #ASCO #Cancer #CenterOfExcellence #LungCancer #HealthcareSystem #OncoDaily #Oncology

🚀 Bladder Cancer Market Insight Series: Week 1   This week, we are diving into critical statistics about bladder cancer diagnosis in the US. Did you know that bladder cancer is the 6th most common cancer? Understanding these numbers is vital for driving innovation and improving patient outcomes.   Stay tuned as we explore more insights and trends in the bladder cancer market throughout this series. Together, we can make a difference in the fight against this disease.   #BladderCancer #Oncology #CancerAwareness #MarketInsights 

Today is Anal Cancer awareness day! The most common type of anal cancer is squamous cell carcinoma, primarily caused by the human papillomavirus (HPV). Although anal cancer is often curable and has an 83% 5-year survival rate for the early stage, if it spreads to distant parts, the 5-year survival rate will drop to only 36%. #analcancer #NGS #oncology #precisionmedicine #cancer#Geneseeq #cancerawareness

🔍 Progression-Free Survival in Endometrial Cancer: Insights from ESMO 2024 Prof Dr els Van Nieuwenhuysen (University Hospitals Leuven) presents findings from the DUO-E trial, showing a significant progression-free survival (PFS) benefit with a durvalumab + carboplatin/paclitaxel, with or without olaparib, in advanced endometrial cancer. Notably, the PFS benefit was consistent across all clinical factors. Discover these updates.👇 For all ESMO 2024 videos, find the link in the comments! #MediMix #ESMO2024 #EndometrialCancer #Oncology #CancerResearch #Immunotherapy #PARPInhibitors

Lung Cancer Awareness Did you know that lung cancer is the leading cause of cancer deaths worldwide? Early detection is key to improving survival rates! The good news is that lung cancer screening is available and recommended for: - Adults 50-80 years old - Current or former smokers (quit within the last 15 years) - Those with a 20 pack-year smoking history Screening can reduce lung cancer deaths by up to 20%! Our study in the Bronx demonstrated lack of awareness, which with need to improved. #LungCancerAwareness #ScreeningSavesLives #EarlyDetectionMatters Esmirna M. Perez Rosario Jorge Octavio Sanchez Orbe Volha Chapiolkina FLOR ROSADO Osman Alvarado American Society of Clinical Oncology (ASCO) Saint Louis University OncoDaily

In May, we acknowledge National Cancer Research Month #NCRM24. Despite the availability of effective cancer treatments, cancer often spreads within the body and invades healthy tissue. Metastasis occurs in all forms of cancer, and in one of the most common forms, colon cancer, metastases cause around 90 percent of all deaths. #Fightcancer Follow us on LinkedIn for more updates. #cancer #oncology #wntresearch #cancerresearch #innovation #drugdevelopment #NCRM24